| 1 |
35115085 | Early B-Type Natriuretic Peptide Change in HFrEF Patients Treated With Sacubitril/Valsartan: A Pooled Analysis of EVALUATE-HF and PROVE-HF. | 2022 Feb |
2 |
| 2 |
35222898 | The Difference between Sacubitril Valsartan and Valsartan on Vascular Endothelial Function, APN, MMP-9, and BNP Levels in Patients with Hypertension and Chronic Heart Failure. | 2022 |
2 |
| 3 |
33823573 | Trend of perceived quality of life and functional capacity in outpatients with chronic heart failure and in treatment with sacubitril/valsartan: a real-life experience. | 2021 Apr 7 |
1 |
| 4 |
34133968 | Active B-Type Natriuretic Peptide Measured by Mass Spectrometry and Response to Sacubitril/Valsartan. | 2021 Nov |
2 |
| 5 |
32951154 | BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor Era. | 2020 Sep 19 |
1 |
| 6 |
30834697 | Beneficial effects of sacubitril/valsartan in heart failure with reduced ejection fraction: pas à cause du BNP? | 2019 May |
1 |
| 7 |
30846338 | B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial. | 2019 Mar 26 |
4 |
| 8 |
30895809 | Effects of sacubitril/valsartan on B-type natriuretic peptide circulating levels and loop diuretic dose in a case series of stabilized heart failure patients with left ventricular ejection fraction ≤35. | 2019 May |
2 |
| 9 |
30898202 | Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays. | 2019 Mar 26 |
3 |
| 10 |
29653636 | Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. | 2018 Apr |
1 |
| 11 |
28652105 | Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan. | 2017 Jul |
1 |
| 12 |
28689178 | Sacubitril/valsartan: beyond natriuretic peptides. | 2017 Oct |
1 |
| 13 |
26280447 | LCZ696 (Valsartan/Sacubitril)--A Possible New Treatment for Hypertension and Heart Failure. | 2016 Jan |
1 |
| 14 |
25878619 | Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure. | 2015 Jan-Feb |
2 |
| 15 |
16159967 | Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure. | 2006 May |
1 |
| 16 |
15864246 | Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). | 2005 Mar |
1 |
| 17 |
15918057 | Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension. | 2005 Jul |
1 |
| 18 |
15632877 | Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT). | 2004 Dec |
1 |
| 19 |
12628948 | Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). | 2003 Mar 11 |
1 |
| 20 |
12411979 | Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts. | 2002 Oct |
1 |
| 21 |
12417542 | Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT). | 2002 Nov 5 |
3 |